WO2020045529A1 - Novel fluorescent dye, composition for lipid droplet staining using same, and method for imaging intracellular lipid droplets using same - Google Patents

Novel fluorescent dye, composition for lipid droplet staining using same, and method for imaging intracellular lipid droplets using same Download PDF

Info

Publication number
WO2020045529A1
WO2020045529A1 PCT/JP2019/033790 JP2019033790W WO2020045529A1 WO 2020045529 A1 WO2020045529 A1 WO 2020045529A1 JP 2019033790 W JP2019033790 W JP 2019033790W WO 2020045529 A1 WO2020045529 A1 WO 2020045529A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
substituted
formyl
heteroaryl
aryl group
Prior art date
Application number
PCT/JP2019/033790
Other languages
French (fr)
Japanese (ja)
Inventor
佑希 立中
公俊 江副
信之 尾関
石山 宗孝
Original Assignee
株式会社同仁化学研究所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社同仁化学研究所 filed Critical 株式会社同仁化学研究所
Publication of WO2020045529A1 publication Critical patent/WO2020045529A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B3/00Dyes with an anthracene nucleus condensed with one or more carbocyclic rings
    • C09B3/14Perylene derivatives
    • C09B3/18Preparation from starting materials already containing the perylene nucleus
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B57/00Other synthetic dyes of known constitution
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Definitions

  • the present invention relates to a novel fluorescent dye which can be suitably used for staining lipid droplets, a composition for staining lipid droplets using the same, and a method for imaging intracellular lipid droplets.
  • Fat droplets also called fat globules, oil droplets, etc.
  • Fat droplets are intracellular organelles that store neutral fats such as triglycerides inside and are surrounded by a monolayer of phospholipids. Fat droplets were mainly present in fat cells, and energy storage was considered to be the main role. Recent studies have shown that lipid droplets are widely present in cells other than fat cells.
  • the fat droplets of fat cells are as large as 10 to 100 ⁇ m, and store a large amount of fat for a long time.
  • the fat droplets of non-adipocytes are much smaller than 1 ⁇ m and temporarily store only a small amount of fat.
  • Cells take up fatty acids from the blood and use them as an energy source, while re-synthesizing some fatty acids into triglycerides and storing them. This is the small fat droplet found in non-fat cells.
  • fat droplets are storage organelles of neutral lipids, and have been regarded simply as fat storage.
  • Recent studies have revealed that lipid droplets play an indispensable role not only in energy storage but also in film formation, intracellular signal transmission, and the like, and are being recognized as important intracellular organelles. (See Non-Patent Document 1) It has also been suggested that intracellular phenomena such as autophagy (see Non-Patent Document 2) and cell senescence (see Non-Patent Document 3) are associated with lipid droplets. It is hoped that the mechanism of fusion and decomposition will be elucidated in detail.
  • lipid droplets are expected to contribute to the diagnosis and treatment of diseases related to neutral lipid droplets such as triacylglycerol and cholesterol ester, the dynamics of lipid droplets in living cells and individuals can be observed. Molecular probes are essential. Lipid droplets form a functionally and morphologically diverse subpopulation, and no single marker has ever existed for staining all lipid droplets.
  • One of the methods for visualizing lipid droplets is to stain a core portion (lipid ester) of the lipid droplets with a molecule having strong lipophilicity.
  • imaging methods using fluorescent dyes such as Nile Red and BODYPY 493/503 have been used to observe the dynamics of lipid droplets in living cells and individuals (for example, Patent Document 1, Non-patent Documents 4 and 5). reference).
  • Nile @ Red is a hydrophobic field probe having a low fluorescence intensity in an aqueous solution and a high fluorescence intensity in a hydrophobic environment, but has background fluorescence in a cell and a poor S / N ratio.
  • Nile @ Red causes a large change in the absorption wavelength region due to solvatochromism (a phenomenon in which the color of a compound changes due to a change in the polarity of a solvent), which affects imaging.
  • solvatochromism a phenomenon in which the color of a compound changes due to a change in the polarity of a solvent
  • observation of multiple stains other than fat droplets is difficult, and it cannot be used in combination with other organelle-specific fluorescent dyes or with other staining methods such as immunostaining.
  • BODYPY 493/503 is a bright green fluorescent dye, which has a unique hydrophobic property and is easily distributed in hydrophobic parts such as fat droplets, so that fat droplets can be detected. However, similar to Nile @ Red, there is background fluorescence in the cells, and the lipid droplet detection specificity is lacking.
  • the present invention has been made in view of the above circumstances, is specific to lipid droplets, enables high-sensitivity fluorescent staining, has no cytotoxicity, has high intracellular retention, and can be applied to dynamic observation of lipid droplets.
  • An object of the present invention is to provide a novel fluorescent dye, a composition for staining lipid droplets using the same, and an imaging method for intracellular lipid droplets.
  • the first aspect of the present invention that meets the above-mentioned object solves the above-mentioned problems by providing a fluorescent dye represented by the following general formula (I), (II) or (III).
  • R 1 and R 2 each independently represent a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted hetero group.
  • R 1 and R 2 is any one of a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group, and a substituted heteroaryl group;
  • R 3 is a functional group represented by any of the following general formulas (i), (ii), and (iii);
  • R 11 is a functional group represented by the following general formula (i); 12 is a nitro group, a cyano group, a sulfonyl group, a sulfoxyl group, a carbonyl group or a carboxyl group,
  • R 4 and R 5 are each independently a hydrocarbon group having 1 to 10 carbon atoms and optionally containing one or both of a branched and unsaturated bond, and R 4 and R 5 are directly or An atom, an oxygen atom, a nitrogen atom and a sulfur atom may be bonded to each other to form a ring
  • R 6 and R 7 are each independently selected from the group consisting of a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group, and R 6 and R 7 At least one of them is a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group or a substituted heteroaryl group
  • R 8 is selected from the group consisting of a hydrogen atom, a cyano group, a formyl group
  • the fluorescent dye according to the first aspect of the present invention is preferably represented by any of the following formulas (1) to (6) and (9).
  • the second aspect of the present invention solves the above-mentioned problems by providing a composition for staining lipid droplets containing one or more fluorescent dyes represented by the following general formulas (I), (II) or (III). Is the solution.
  • R 1 and R 2 each independently represent a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group, and a substituted heteroaryl Selected from the group consisting of groups, and at least one of R 1 and R 2 is any one of a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group, and a substituted heteroaryl group;
  • R 3 is a formyl group or a functional group represented by any of the following general formulas (i), (ii) and (iii), and R 11 is a functional group represented by the following general formula (i)
  • R 12 is any one of a nitro group, a cyano group, a sulfonyl group, a sulfoxyl group, a carbonyl group and a carboxyl group;
  • R 4 and R 5 are each independently a hydrocarbon group having 1 to 10 carbon atoms and optionally containing one or both of a branched and unsaturated bond, and R 4 and R 5 are directly or An atom, an oxygen atom, a nitrogen atom and a sulfur atom may be bonded to each other to form a ring
  • R 6 and R 7 are each independently selected from the group consisting of a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group, and R 6 and R 7 At least one of them is a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group or a substituted heteroaryl group
  • R 8 is selected from the group consisting of a hydrogen atom, a cyano group, a formyl group
  • a step of introducing one or a plurality of fluorescent dyes represented by the following general formulas (I), (II) or (III) into lipid droplets in cells is achieved by providing a method for imaging intracellular lipid droplets, which comprises a step of measuring fluorescence emitted from the fluorescent dye introduced into the lipid droplets.
  • R 1 and R 2 each independently represent a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted hetero group.
  • R 1 and R 2 is any one of a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group, and a substituted heteroaryl group;
  • R 3 is a formyl group or a functional group represented by any of the following general formulas (i), (ii) and (iii), and
  • R 11 is a functional group represented by the following general formula (i)
  • R 12 is any one of a nitro group, a cyano group, a sulfonyl group, a sulfoxyl group, a carbonyl group and a carboxyl group;
  • R 4 and R 5 are each independently a hydrocarbon group having 1 to 10 carbon atoms and optionally containing one or both of a branched and unsaturated bond, and R 4 and R 5 are directly or An atom, an oxygen atom, a nitrogen atom and a sulfur atom may be bonded to each other to form a ring
  • R 6 and R 7 are each independently selected from the group consisting of a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group, and R 6 and R 7 At least one of them is a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group or a substituted heteroaryl group
  • R 8 is selected from the group consisting of a hydrogen atom, a cyano group, a formyl group
  • the fluorescent dye is represented by the following formulas (1) to (9). It is preferable to be represented by any of them.
  • lipid droplet specificity is high, and strong fluorescence is emitted in a hydrophobic environment such as a lipid droplet, but little background emission is exhibited in a hydrophilic environment such as a cytoplasm and fluorescence observation with high sensitivity Is provided.
  • the fluorescent dye of the present invention has naphthalene, pyrene or perylene as a fluorescent chromophore, it is relatively easy to synthesize, and has a desired fluorescent property (excitation spectrum, fluorescence spectrum, etc.) by molecular design. Design dyes. This makes it possible not only to observe clear lipid droplets in cells but also to realize multiple staining for studying the relationship with other organelles by combining fluorescent dyes having different wavelengths.
  • the fluorescent dye of the present invention has low cytotoxicity and high retention in lipid droplets, the dynamics of lipid droplets in living cells can be observed for a long time.
  • a fluorescent dye as a useful tool for analyzing the biological function of lipid droplets in living cells, a composition for staining lipid droplets using the same, and an imaging method for intracellular lipid droplets are disclosed. Provided.
  • FIG. 9 is a view showing a measurement result of flow cytometry in Example 3.
  • 10 is a histogram showing the relationship between each cell group and the fluorescence intensity obtained from the results of flow cytometry in Example 3.
  • the fluorescent dye according to the first embodiment of the present invention (may be simply referred to as “fluorescent dye”) is represented by the following general formula (I), (II) or (III). .
  • R 1 and R 2 each independently represent a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted hetero group.
  • R 1 and R 2 is any one of a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group, and a substituted heteroaryl group;
  • R 3 is a functional group represented by any of the following general formulas (i), (ii), and (iii);
  • R 11 is a functional group represented by the following general formula (i); 12 is a nitro group, a cyano group, a sulfonyl group, a sulfoxyl group, a carbonyl group or a carboxyl group,
  • R 4 and R 5 are each independently a hydrocarbon group having 1 to 10 carbon atoms and optionally containing one or both of a branched and unsaturated bond, and R 4 and R 5 are directly or One or more of an atom, an oxygen atom, a nitrogen atom (amino group) and a sulfur atom (thioether group, sulfinyl group or sulfonyl group) (a ring in which a nitrogen atom, an oxygen atom and a sulfur atom are formed as constituents of a functional group) May also be included within the group) to form a ring, R 6 and R 7 are each independently selected from the group consisting of a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group, and R 6 and R 7 At least one of them is a cyano group
  • Compounds (1) to (8) can be synthesized by using any available method using a commercially available pyrene or perylene derivative as a starting material.
  • compound (3), compound (5) and compound (6) can be synthesized according to the following scheme.
  • Compounds (1) and (4) can be synthesized from an aldehyde derivative using the same reagents and conditions as in the reaction for synthesizing compound (6) from compound (5).
  • the compound (2) can be synthesized by reacting 3-bromoperylene or perylene-3-ylboronic acid with an amine using a metal catalyst.
  • Compound (9) can be synthesized, for example, by reacting 1-nitronaphthalene-4-sulfonyl chloride with Nile Blue according to the following scheme.
  • composition for fat droplet dyeing is the present invention described above.
  • Ie one or more of the fluorescent dyes represented by the above general formulas (I), (II) or (III).
  • Specific examples of preferred fluorescent dyes that can be used in the composition include those represented by any of the following formulas (1) to (9).
  • the compound (7) and the compound (8) are known compounds, but can be preferably used for the composition.
  • the composition may be in the form of a solid containing one or more of the above-mentioned fluorescent dyes, or in the form of a liquid in which one or more of the above-mentioned fluorescent dyes is dissolved in an appropriate solvent, solution or buffer solution. There may be.
  • the composition for lipid droplet staining may comprise one or more other dyes that can be used for specific or non-specific staining of lipid droplets or other organelles.
  • imaging method may be any of the above general formulas (I), (II) and (III).
  • imaging method may be any of the above general formulas (I), (II) and (III).
  • Fluorescent dyes used in the imaging method and preferred specific examples thereof are the same as in the case of the composition for staining lipid droplets according to the second embodiment of the present invention, and thus detailed description is omitted.
  • the introduction of the fluorescent dye into the lipid droplets can be performed using any known method.
  • the fluorescent dye can be added to cells seeded in a medium and incubated for a predetermined time.
  • the measurement of the fluorescence emitted from the fluorescent dye introduced inside the fat droplet can be performed using any known means, but can be performed by observing a fluorescent image using a confocal microscope or a fluorescent microscope. it can. Since the above-described fluorescent dye used in the imaging method has low cytotoxicity and high retention in fat droplets, it is possible to observe fat droplets in living cells over time.
  • Example 1 Synthesis of Fluorescent Dye [1]: Synthesis of Compounds (7) and (3) The synthesis of compounds (7) and (3) each having a 1- (4-methoxyphenyl) ethenyl group was as follows. According to the scheme shown, the reaction was carried out using a Wittig reaction between an aldehyde derivative and (4-methoxybenzyl) triphenylphosphonium chloride.
  • Example 2 Staining of lipid droplets in cells (1)
  • the lipid droplets are small, but fat is added by adding oleic acid.
  • the staining characteristics of lipid droplets were examined using HeLa cells capable of inducing droplets and HepG2 cells having a high lipid droplet content.
  • HeLa cells were seeded in ⁇ -slide 8 well (Ibidi), 200 ⁇ mol / L oleic acid diluted with a serum medium was added, and the cells were cultured overnight at 37 ° C. in a CO 2 incubator.
  • 0.1 ⁇ mol / L of the compound (7) and the compound (3) diluted with a serum medium were added, and 1 ⁇ mol / L of the compound (6) was added, and the mixture was incubated for 30 minutes. Thereafter, observation was performed with a confocal microscope.
  • HepG2 cells were seeded in ⁇ -slide 8 well (Ibidi) and cultured overnight at 37 ° C. in a CO 2 incubator.
  • 0.1 ⁇ mol / L of the compound (7) and the compound (3) diluted with a serum medium were added, and 1 ⁇ mol / L of the compound (6) was added, and the mixture was incubated for 30 minutes. Thereafter, observation was performed with a confocal microscope.
  • FIG. 4 shows the results.
  • Nile @ Red and BODYPY @ 493/503 have low intracellular retention properties, and after 24 hours from the staining, the dye leaks out of the cells and a fluorescent image specific to lipid droplets cannot be observed.
  • compound (3) the fluorescence image specific to the lipid droplets is maintained even after 24 hours from the staining, the retention in the cell is high, and the lipid droplets are observed for a long period of time. It was confirmed that it was possible.
  • Example 3 Staining of lipid droplets in cells (2)
  • the flow cytometer can detect the fluorescence intensity of each individual cell simply, quickly and with high sensitivity, and can quantify the characteristics of the cell population.
  • a higher lipid droplet specificity is required because the detected fluorescent signal depends on the amount of fluorescent dye labeled on the cells.
  • cells sometimes cause autofluorescence in a short wavelength region. Excitation by a 488 nm laser caused by a constituent material of the cell causes slight emission even without fluorescent staining, and false positives may be detected. On the longer wavelength side, auto-fluorescence interference is reduced, and a fluorescent dye that emits fluorescence exceeding 600 nm is required.
  • evaluation of the amount of intracellular lipid droplets by a flow cytometer was examined.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

The present invention discloses a fluorescent dye represented by general formula (I), (II) or (III), which is specific to lipid droplets and enables lipid droplet staining with high sensitivity, while having no cytotoxicity and high intracellular retentivity, and which is applicable for kinetics observation of lipid droplets. The present invention also discloses a composition for lipid droplet staining and a method for imaging intracellular lipid droplets, each of which uses this fluorescent dye. In the formulae, each of R1 and R2 independently represents a hydrogen atom or a group that is selected from the group consisting of a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group, with at least one of R1 and R2 being a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group or a substituted heteroaryl group; R3 represents a functional group represented by general formula (i), (ii) or (iii); R11 represents a functional group represented by general formula (i); and R12 represents a nitro group, a cyano group, a sulfonyl group, a sulfoxyl group, a carbonyl group or a carboxyl group.

Description

新規な蛍光色素並びにそれを用いた脂肪滴染色用組成物及び細胞内脂肪滴のイメージング方法Novel fluorescent dye, composition for staining lipid droplets using the same, and method for imaging intracellular lipid droplets
 本発明は、脂肪滴の染色に好適に用いることができる新規な蛍光色素並びにそれを用いた脂肪滴染色用組成物及び細胞内脂肪滴のイメージング方法に関する。 The present invention relates to a novel fluorescent dye which can be suitably used for staining lipid droplets, a composition for staining lipid droplets using the same, and a method for imaging intracellular lipid droplets.
 脂肪滴(脂肪球、油滴等ともいう)は、内部にトリグリセリド等の中性脂肪を貯蔵し、リン脂質の一重層によって周囲を囲まれた細胞内小器官である。脂肪滴は、主に脂肪細胞に存在し、エネルギーの貯蔵が主な役割であると考えられていた。近年の研究により、脂肪滴は脂肪細胞以外の細胞にも広く存在していることがわかっている。 Fat droplets (also called fat globules, oil droplets, etc.) are intracellular organelles that store neutral fats such as triglycerides inside and are surrounded by a monolayer of phospholipids. Fat droplets were mainly present in fat cells, and energy storage was considered to be the main role. Recent studies have shown that lipid droplets are widely present in cells other than fat cells.
 脂肪細胞の脂肪滴は10~100μmと巨大であり、大量の脂肪を長期にわたって貯蔵する。しかし、非脂肪細胞の脂肪滴は1μm以下とはるかに小さく、ごく少量の脂肪を一時的に保管している。細胞は、血液から脂肪酸を取り込み、エネルギー源として利用するが、その際に一部の脂肪酸をトリグリセリドに再合成し、貯蔵する。これが、非脂肪細胞に見られる小さな脂肪滴である。 脂肪 The fat droplets of fat cells are as large as 10 to 100 μm, and store a large amount of fat for a long time. However, the fat droplets of non-adipocytes are much smaller than 1 μm and temporarily store only a small amount of fat. Cells take up fatty acids from the blood and use them as an energy source, while re-synthesizing some fatty acids into triglycerides and storing them. This is the small fat droplet found in non-fat cells.
 上述のように、従来、脂肪滴は中性脂質の貯蔵オルガネラであり、単なる脂肪の貯蔵庫とされていた。しかし、最近の研究から脂肪滴表面には多くのタンパク質が存在し、体内の脂質代謝制御において重要な役割を担っていることが明らかになってきている。脂肪の蓄積や分解は厳密に調節されており、その破綻は肥満や糖尿病といった種々の疾患を招くとされている。近年の研究により、脂肪滴は、エネルギーの貯蔵のみならず、膜形成、細胞内シグナル伝達等に不可欠な役割を果たしていることが明らかになり、細胞内の重要なオルガネラとして認知されつつある。(非特許文献1参照)オートファジー(非特許文献2参照)、細胞老化(非特許文献3参照)といった細胞内現象と脂肪滴との関連性も示唆されており、脂肪滴の形成・成長・融合・分解のメカニズムが詳細に解明されることが待ち望まれている。 脂肪 As described above, conventionally, fat droplets are storage organelles of neutral lipids, and have been regarded simply as fat storage. However, recent studies have revealed that many proteins exist on the surface of lipid droplets and play an important role in regulating lipid metabolism in the body. Fat accumulation and decomposition are strictly regulated, and its breakdown is said to lead to various diseases such as obesity and diabetes. Recent studies have revealed that lipid droplets play an indispensable role not only in energy storage but also in film formation, intracellular signal transmission, and the like, and are being recognized as important intracellular organelles. (See Non-Patent Document 1) It has also been suggested that intracellular phenomena such as autophagy (see Non-Patent Document 2) and cell senescence (see Non-Patent Document 3) are associated with lipid droplets. It is hoped that the mechanism of fusion and decomposition will be elucidated in detail.
 したがって、脂肪滴の形成・成長・融合・分解のメカニズムが詳細に解明されるための、高い脂肪滴特異性を持つ蛍光色素は近年大きな関心を集めている。脂肪滴は、トリアシルグリセロールやコレステロールエステルなどの中性脂肪滴に関する疾患の診断・治療に寄与する新たな研究展開が期待されることから、生細胞内や個体内の脂肪滴の動態を観察できる分子プローブは必要不可欠である。脂肪滴は機能的及び形態学的に多様な亜集団を形成し、すべての脂肪滴を染色するための単一のマーカーはこれまで存在しなかった。脂肪滴を可視化する方法の一つは、脂肪親和性の強い分子で脂肪滴の核部分(脂質エステル)を染色することである。生細胞や個体内の脂肪滴動態を観察するために、従来より、Nile Red、BODYPY 493/503等の蛍光色素によるイメージング法が用いられてきた(例えば、特許文献1、非特許文献4、5参照)。 蛍 光 Therefore, fluorescent dyes with high lipid droplet specificity, for elucidating the mechanism of formation, growth, fusion and decomposition of lipid droplets in detail, have attracted great interest in recent years. Since lipid droplets are expected to contribute to the diagnosis and treatment of diseases related to neutral lipid droplets such as triacylglycerol and cholesterol ester, the dynamics of lipid droplets in living cells and individuals can be observed. Molecular probes are essential. Lipid droplets form a functionally and morphologically diverse subpopulation, and no single marker has ever existed for staining all lipid droplets. One of the methods for visualizing lipid droplets is to stain a core portion (lipid ester) of the lipid droplets with a molecule having strong lipophilicity. Conventionally, imaging methods using fluorescent dyes such as Nile Red and BODYPY 493/503 have been used to observe the dynamics of lipid droplets in living cells and individuals (for example, Patent Document 1, Non-patent Documents 4 and 5). reference).
特許第6241014号公報Japanese Patent No. 624014
 しかしながら、Nile Redは、水溶液下において蛍光強度が低く、疎水性環境下において高い蛍光強度を示す疎水場プローブであるが、細胞内でバックグラウンド蛍光があり、S/N比が悪い。また、Nile Redは、ソルバトクロミズム(溶媒の極性の変化によって化合物の色調が変化する現象。)により、吸収波長領域が大きく変化し、イメージングに影響を及ぼしてしまう。さらに、脂肪滴以外の多重染色観察が困難であり、他のオルガネラ特異的蛍光色素との併用や、免疫染色等の他の染色法との併用ができない。 However, Nile @ Red is a hydrophobic field probe having a low fluorescence intensity in an aqueous solution and a high fluorescence intensity in a hydrophobic environment, but has background fluorescence in a cell and a poor S / N ratio. In addition, Nile @ Red causes a large change in the absorption wavelength region due to solvatochromism (a phenomenon in which the color of a compound changes due to a change in the polarity of a solvent), which affects imaging. Furthermore, observation of multiple stains other than fat droplets is difficult, and it cannot be used in combination with other organelle-specific fluorescent dyes or with other staining methods such as immunostaining.
 BODYPY 493/503は、明るい緑色蛍光色素で、特有の疎水性を持ち、脂肪滴などの疎水性部分に分布しやすいため、脂肪滴検出が可能である。しかし、Nile Redと同様に細胞内でバックグラウンド蛍光があり、脂肪滴検出特異性に欠ける。 BODYPY 493/503 is a bright green fluorescent dye, which has a unique hydrophobic property and is easily distributed in hydrophobic parts such as fat droplets, so that fat droplets can be detected. However, similar to Nile @ Red, there is background fluorescence in the cells, and the lipid droplet detection specificity is lacking.
 また、脂肪滴の動態を観察するためには、細胞に蛍光色素を導入後長期培養する必要がある。しかし、これらの色素は細胞毒性や細胞内滞留性に課題を抱えており、長期間の観察には適していない。 Furthermore, in order to observe the dynamics of lipid droplets, it is necessary to carry out long-term culture after introducing a fluorescent dye into cells. However, these dyes have problems in cytotoxicity and retention in cells, and are not suitable for long-term observation.
 本発明はかかる事情に鑑みてなされたもので、脂肪滴に特異的で、高感度な蛍光染色が可能で、細胞毒性がなく、細胞内滞留性が高く、脂肪滴の動態観察にも適用可能な蛍光色素並びにそれを用いた脂肪滴染色用組成物及び細胞内脂肪滴のイメージング方法を提供することを目的とする。 The present invention has been made in view of the above circumstances, is specific to lipid droplets, enables high-sensitivity fluorescent staining, has no cytotoxicity, has high intracellular retention, and can be applied to dynamic observation of lipid droplets. An object of the present invention is to provide a novel fluorescent dye, a composition for staining lipid droplets using the same, and an imaging method for intracellular lipid droplets.
 前記目的に沿う本発明の第1の態様は、下記の一般式(I)、(II)又は(III)で表される蛍光色素を提供することにより上記課題を解決するものである。 The first aspect of the present invention that meets the above-mentioned object solves the above-mentioned problems by providing a fluorescent dye represented by the following general formula (I), (II) or (III).
Figure JPOXMLDOC01-appb-C000019
Figure JPOXMLDOC01-appb-C000019
Figure JPOXMLDOC01-appb-C000020
Figure JPOXMLDOC01-appb-C000020
Figure JPOXMLDOC01-appb-C000021
Figure JPOXMLDOC01-appb-C000021
 上記一般式(I)、(II)及び(III)において、R及びRは、それぞれ独立して、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、且つR及びRのうち少なくとも一方は、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基のいずれかであり、
 Rは、下記の一般式(i)、(ii)及び(iii)のいずれかで表される官能基、R11は、下記の一般式(i)で表される官能基であり、R12は、ニトロ基、シアノ基、スルホニル基、スルホキシル基、カルボニル基及びカルボキシル基のいずれかであり、
In the above general formulas (I), (II) and (III), R 1 and R 2 each independently represent a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted hetero group. Selected from the group consisting of aryl groups, and at least one of R 1 and R 2 is any one of a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group, and a substituted heteroaryl group;
R 3 is a functional group represented by any of the following general formulas (i), (ii), and (iii); R 11 is a functional group represented by the following general formula (i); 12 is a nitro group, a cyano group, a sulfonyl group, a sulfoxyl group, a carbonyl group or a carboxyl group,
Figure JPOXMLDOC01-appb-C000022
Figure JPOXMLDOC01-appb-C000022
 上記一般式(i)、(ii)及び(iii)において、
 R及びRは、それぞれ独立して、炭素数1~10の、分岐及び不飽和結合の一方又は双方を含んでいてもよい炭化水素基であり、R及びRは、直接或いは炭素原子、酸素原子、窒素原子及び硫黄原子のいずれかを介して結合し、環を形成していてもよく、
 R及びRは、それぞれ独立して、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、且つR及びRのうち少なくとも一方は、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基のいずれかであり、
 Rは、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、
 R及びR10は、それぞれ独立して、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、且つR及びR10のうち少なくとも一方は、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基のいずれかである。
In the above general formulas (i), (ii) and (iii),
R 4 and R 5 are each independently a hydrocarbon group having 1 to 10 carbon atoms and optionally containing one or both of a branched and unsaturated bond, and R 4 and R 5 are directly or An atom, an oxygen atom, a nitrogen atom and a sulfur atom may be bonded to each other to form a ring,
R 6 and R 7 are each independently selected from the group consisting of a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group, and R 6 and R 7 At least one of them is a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group or a substituted heteroaryl group,
R 8 is selected from the group consisting of a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group;
R 9 and R 10 are each independently selected from the group consisting of a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group, and R 9 and R 10 At least one of them is any of a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group, and a substituted heteroaryl group.
 本発明の第1の態様に係る蛍光色素は、好ましくは、下記の式(1)~(6)及び(9)のいずれかで表される。 蛍 光 The fluorescent dye according to the first aspect of the present invention is preferably represented by any of the following formulas (1) to (6) and (9).
Figure JPOXMLDOC01-appb-C000023
Figure JPOXMLDOC01-appb-C000023
Figure JPOXMLDOC01-appb-C000024
Figure JPOXMLDOC01-appb-C000024
 本発明の第2の態様は、下記の一般式(I)、(II)又は(III)で表される1又は複数の蛍光色素を含む脂肪滴染色用組成物を提供することにより上記課題を解決するものである。 The second aspect of the present invention solves the above-mentioned problems by providing a composition for staining lipid droplets containing one or more fluorescent dyes represented by the following general formulas (I), (II) or (III). Is the solution.
Figure JPOXMLDOC01-appb-C000025
Figure JPOXMLDOC01-appb-C000025
Figure JPOXMLDOC01-appb-C000026
Figure JPOXMLDOC01-appb-C000026
Figure JPOXMLDOC01-appb-C000027
Figure JPOXMLDOC01-appb-C000027
 上記一般式(I)(II)及び(III)において、R及びRは、それぞれ独立して、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、且つR及びRのうち少なくとも一方は、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基のいずれかであり、
 Rは、ホルミル基又は下記の一般式(i)、(ii)及び(iii)のいずれかで表される官能基、R11は、下記の一般式(i)で表される官能基であり、R12は、ニトロ基、シアノ基、スルホニル基、スルホキシル基、カルボニル基及びカルボキシル基のいずれかであり、
In the general formulas (I), (II) and (III), R 1 and R 2 each independently represent a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group, and a substituted heteroaryl Selected from the group consisting of groups, and at least one of R 1 and R 2 is any one of a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group, and a substituted heteroaryl group;
R 3 is a formyl group or a functional group represented by any of the following general formulas (i), (ii) and (iii), and R 11 is a functional group represented by the following general formula (i) R 12 is any one of a nitro group, a cyano group, a sulfonyl group, a sulfoxyl group, a carbonyl group and a carboxyl group;
Figure JPOXMLDOC01-appb-C000028
Figure JPOXMLDOC01-appb-C000028
 上記一般式(i)、(ii)及び(iii)において、
 R及びRは、それぞれ独立して、炭素数1~10の、分岐及び不飽和結合の一方又は双方を含んでいてもよい炭化水素基であり、R及びRは、直接或いは炭素原子、酸素原子、窒素原子及び硫黄原子のいずれかを介して結合し、環を形成していてもよく、
 R及びRは、それぞれ独立して、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、且つR及びRのうち少なくとも一方は、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基のいずれかであり、
 Rは、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、
 R及びR10は、それぞれ独立して、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、且つR及びR10のうち少なくとも一方は、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基のいずれかである。
In the above general formulas (i), (ii) and (iii),
R 4 and R 5 are each independently a hydrocarbon group having 1 to 10 carbon atoms and optionally containing one or both of a branched and unsaturated bond, and R 4 and R 5 are directly or An atom, an oxygen atom, a nitrogen atom and a sulfur atom may be bonded to each other to form a ring,
R 6 and R 7 are each independently selected from the group consisting of a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group, and R 6 and R 7 At least one of them is a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group or a substituted heteroaryl group,
R 8 is selected from the group consisting of a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group;
R 9 and R 10 are each independently selected from the group consisting of a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group, and R 9 and R 10 At least one of them is any of a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group, and a substituted heteroaryl group.
 本発明の第3の態様は、下記の一般式(I)、(II)又は(III)で表される1又は複数の蛍光色素を細胞内の脂肪滴の内部に導入する工程と、
 脂肪滴の内部に導入された前記蛍光色素から放出される蛍光を測定する工程を含むことを特徴とする細胞内脂肪滴のイメージング方法を提供することにより上記課題を解決するものである。
In a third aspect of the present invention, a step of introducing one or a plurality of fluorescent dyes represented by the following general formulas (I), (II) or (III) into lipid droplets in cells:
The object is achieved by providing a method for imaging intracellular lipid droplets, which comprises a step of measuring fluorescence emitted from the fluorescent dye introduced into the lipid droplets.
Figure JPOXMLDOC01-appb-C000029
Figure JPOXMLDOC01-appb-C000029
Figure JPOXMLDOC01-appb-C000030
Figure JPOXMLDOC01-appb-C000030
Figure JPOXMLDOC01-appb-C000031
Figure JPOXMLDOC01-appb-C000031
 上記一般式(I)、(II)及び(III)において、R及びRは、それぞれ独立して、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、且つR及びRのうち少なくとも一方は、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基のいずれかであり、
 Rは、ホルミル基又は下記の一般式(i)、(ii)及び(iii)のいずれかで表される官能基、R11は、下記の一般式(i)で表される官能基であり、R12は、ニトロ基、シアノ基、スルホニル基、スルホキシル基、カルボニル基及びカルボキシル基のいずれかであり、
In the above general formulas (I), (II) and (III), R 1 and R 2 each independently represent a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted hetero group. Selected from the group consisting of aryl groups, and at least one of R 1 and R 2 is any one of a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group, and a substituted heteroaryl group;
R 3 is a formyl group or a functional group represented by any of the following general formulas (i), (ii) and (iii), and R 11 is a functional group represented by the following general formula (i) R 12 is any one of a nitro group, a cyano group, a sulfonyl group, a sulfoxyl group, a carbonyl group and a carboxyl group;
Figure JPOXMLDOC01-appb-C000032
Figure JPOXMLDOC01-appb-C000032
 上記一般式(i)、(ii)及び(iii)において、
 R及びRは、それぞれ独立して、炭素数1~10の、分岐及び不飽和結合の一方又は双方を含んでいてもよい炭化水素基であり、R及びRは、直接或いは炭素原子、酸素原子、窒素原子及び硫黄原子のいずれかを介して結合し、環を形成していてもよく、
 R及びRは、それぞれ独立して、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、且つR及びRのうち少なくとも一方は、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基のいずれかであり、
 Rは、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、
 R及びR10は、それぞれ独立して、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、且つR及びR10のうち少なくとも一方は、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基のいずれかである。
In the above general formulas (i), (ii) and (iii),
R 4 and R 5 are each independently a hydrocarbon group having 1 to 10 carbon atoms and optionally containing one or both of a branched and unsaturated bond, and R 4 and R 5 are directly or An atom, an oxygen atom, a nitrogen atom and a sulfur atom may be bonded to each other to form a ring,
R 6 and R 7 are each independently selected from the group consisting of a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group, and R 6 and R 7 At least one of them is a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group or a substituted heteroaryl group,
R 8 is selected from the group consisting of a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group;
R 9 and R 10 are each independently selected from the group consisting of a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group, and R 9 and R 10 At least one of them is any of a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group, and a substituted heteroaryl group.
 本発明の第2の態様に係る脂肪滴染色用組成物および本発明の第3の態様に係る細胞内脂肪滴のイメージング方法において、前記蛍光色素が、下記の式(1)~(9)のいずれかで表されるものであることが好ましい。 In the composition for staining lipid droplets according to the second aspect of the present invention and the method for imaging intracellular lipid droplets according to the third aspect of the present invention, the fluorescent dye is represented by the following formulas (1) to (9). It is preferable to be represented by any of them.
Figure JPOXMLDOC01-appb-C000033
Figure JPOXMLDOC01-appb-C000033
Figure JPOXMLDOC01-appb-C000034
Figure JPOXMLDOC01-appb-C000034
 本発明によると、脂肪滴特異性が高く、脂肪滴等の疎水性環境下では強い蛍光発光を起こす一方、細胞質等の親水性環境下においてバックグラウンド発光を殆ど示さず、高感度での蛍光観察が可能な蛍光色素が提供される。本発明の蛍光色素は、ナフタレン、ピレン又はペリレンを蛍光発色団として有しているため、合成が比較的容易であり、分子設計により、所望の蛍光特性(励起スペクトル、蛍光スペクトル等)を有する蛍光色素をデザインできる。これにより、細胞中の明瞭な脂肪滴の観察のみならず、異なる波長をもつ蛍光色素を組み合わせることにより、他のオルガネラとの関連性を研究するための多重染色を実現できる。更に、本発明の蛍光色素は、細胞毒性が低く、脂肪滴内部への滞留性が高いため、長時間にわたり、生細胞内の脂肪滴の動態を観察できる。このように、本発明によると、生細胞内の脂肪滴の生体機能を解析する上で有用なツールとしての蛍光色素、これを用いた脂肪滴染色用組成物及び細胞内脂肪滴のイメージング方法が提供される。 According to the present invention, lipid droplet specificity is high, and strong fluorescence is emitted in a hydrophobic environment such as a lipid droplet, but little background emission is exhibited in a hydrophilic environment such as a cytoplasm and fluorescence observation with high sensitivity Is provided. Since the fluorescent dye of the present invention has naphthalene, pyrene or perylene as a fluorescent chromophore, it is relatively easy to synthesize, and has a desired fluorescent property (excitation spectrum, fluorescence spectrum, etc.) by molecular design. Design dyes. This makes it possible not only to observe clear lipid droplets in cells but also to realize multiple staining for studying the relationship with other organelles by combining fluorescent dyes having different wavelengths. Furthermore, since the fluorescent dye of the present invention has low cytotoxicity and high retention in lipid droplets, the dynamics of lipid droplets in living cells can be observed for a long time. As described above, according to the present invention, a fluorescent dye as a useful tool for analyzing the biological function of lipid droplets in living cells, a composition for staining lipid droplets using the same, and an imaging method for intracellular lipid droplets are disclosed. Provided.
オレイン酸処理後、本発明の化合物と共にインキュベートしたHeLa細胞の共焦点顕微鏡観察の結果を示す写真である。It is a photograph which shows the result of the confocal microscope observation of the HeLa cell incubated with the compound of this invention after oleic acid treatment. オレイン酸処理後、本発明の化合物及びNile Redと共にインキュベートしたHeLa細胞の共焦点顕微鏡観察の結果を示す写真である。It is a photograph which shows the result of the confocal microscope observation of the HeLa cell incubated with the compound of this invention and Nile @ Red after oleic acid treatment. オレイン酸処理後、本発明の化合物、Nile Red又はBODYPY 493/503と共にインキュベートしたHeLa細胞の共焦点顕微鏡観察の結果を示す写真である。It is a photograph which shows the result of the confocal microscope observation of the HeLa cell incubated with the compound of this invention, Nile @ Red or BODYPY @ 493/503 after oleic acid treatment. 本発明の化合物、Nile Red又はBODYPY 493/503と共にインキュベートし、24時間経過後のHepG2細胞の共焦点顕微鏡観察の結果を示す写真である。It is the photograph which shows the result of the confocal microscope observation of HepG2 cell after incubating with the compound of this invention, Nile @ Red or BODYPY @ 493/503, and after 24 hours. 実施例3におけるフローサイトメトリーの測定結果を示す図である。FIG. 9 is a view showing a measurement result of flow cytometry in Example 3. 実施例3におけるフローサイトメトリーの結果より得られた、各細胞群と蛍光強度との関係を示すヒストグラムである。10 is a histogram showing the relationship between each cell group and the fluorescence intensity obtained from the results of flow cytometry in Example 3.
 本発明の第1の実施の形態に係る蛍光色素(単に、「蛍光色素」と略称される場合がある。)は、下記の一般式(I)、(II)又は(III)で表される。 The fluorescent dye according to the first embodiment of the present invention (may be simply referred to as “fluorescent dye”) is represented by the following general formula (I), (II) or (III). .
Figure JPOXMLDOC01-appb-C000035
Figure JPOXMLDOC01-appb-C000035
Figure JPOXMLDOC01-appb-C000036
Figure JPOXMLDOC01-appb-C000036
Figure JPOXMLDOC01-appb-C000037
Figure JPOXMLDOC01-appb-C000037
 上記一般式(I)、(II)及び(III)において、R及びRは、それぞれ独立して、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、且つR及びRのうち少なくとも一方は、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基のいずれかであり、
 Rは、下記の一般式(i)、(ii)及び(iii)のいずれかで表される官能基、R11は、下記の一般式(i)で表される官能基であり、R12は、ニトロ基、シアノ基、スルホニル基、スルホキシル基、カルボニル基及びカルボキシル基のいずれかであり、
In the above general formulas (I), (II) and (III), R 1 and R 2 each independently represent a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted hetero group. Selected from the group consisting of aryl groups, and at least one of R 1 and R 2 is any one of a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group, and a substituted heteroaryl group;
R 3 is a functional group represented by any of the following general formulas (i), (ii), and (iii); R 11 is a functional group represented by the following general formula (i); 12 is a nitro group, a cyano group, a sulfonyl group, a sulfoxyl group, a carbonyl group or a carboxyl group,
Figure JPOXMLDOC01-appb-C000038
Figure JPOXMLDOC01-appb-C000038
 上記一般式(i)、(ii)及び(iii)において、
 R及びRは、それぞれ独立して、炭素数1~10の、分岐及び不飽和結合の一方又は双方を含んでいてもよい炭化水素基であり、R及びRは、直接或いは炭素原子、酸素原子、窒素原子(アミノ基)及び硫黄原子(チオエーテル基、スルフィニル基又はスルホニル基)のいずれか1又は複数(窒素原子、酸素原子及び硫黄原子が官能基の構成要素として形成される環内に含まれている場合も含まれる。)を介して結合し、環を形成していてもよく、
 R及びRは、それぞれ独立して、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、且つR及びRのうち少なくとも一方は、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基のいずれかであり、
 Rは、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、
 R及びR10は、それぞれ独立して、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、且つR及びR10のうち少なくとも一方は、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基のいずれかである。
In the above general formulas (i), (ii) and (iii),
R 4 and R 5 are each independently a hydrocarbon group having 1 to 10 carbon atoms and optionally containing one or both of a branched and unsaturated bond, and R 4 and R 5 are directly or One or more of an atom, an oxygen atom, a nitrogen atom (amino group) and a sulfur atom (thioether group, sulfinyl group or sulfonyl group) (a ring in which a nitrogen atom, an oxygen atom and a sulfur atom are formed as constituents of a functional group) May also be included within the group) to form a ring,
R 6 and R 7 are each independently selected from the group consisting of a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group, and R 6 and R 7 At least one of them is a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group or a substituted heteroaryl group,
R 8 is selected from the group consisting of a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group;
R 9 and R 10 are each independently selected from the group consisting of a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group, and R 9 and R 10 At least one of them is any of a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group, and a substituted heteroaryl group.
 上記一般式(I)、(II)又は(III)で表される蛍光色素のうち、好ましいものの具体例としては、下記の式(1)~(6)及び(9)のいずれかで表されるものが挙げられる。以下、「式(n)で表される化合物(nは整数)」を「化合物n」と略称する場合がある。 Among the fluorescent dyes represented by the general formulas (I), (II) or (III), preferred specific examples are represented by any of the following formulas (1) to (6) and (9). Things. Hereinafter, the “compound represented by the formula (n) (n is an integer)” may be abbreviated as “compound n”.
Figure JPOXMLDOC01-appb-C000039
Figure JPOXMLDOC01-appb-C000039
Figure JPOXMLDOC01-appb-C000040
Figure JPOXMLDOC01-appb-C000040
 化合物(1)~(8)は、入手可能なピレン又はペリレン誘導体を出発物質として任意の公知の方法を用いて合成することができる。例えば、化合物(3)、化合物(5)及び化合物(6)は、下記のスキームに従って合成することができる。 Compounds (1) to (8) can be synthesized by using any available method using a commercially available pyrene or perylene derivative as a starting material. For example, compound (3), compound (5) and compound (6) can be synthesized according to the following scheme.
Figure JPOXMLDOC01-appb-C000041
Figure JPOXMLDOC01-appb-C000041
Figure JPOXMLDOC01-appb-C000042
Figure JPOXMLDOC01-appb-C000042
 化合物(1)、(4)は、化合物(5)から化合物(6)を合成する反応と同様の試薬、条件を用いて、アルデヒド誘導体から合成することができる。また、化合物(2)は、金属触媒を用いた3-ブロモペリレン又はペリレン-3-イルボロン酸とアミンの反応により合成することができる。 Compounds (1) and (4) can be synthesized from an aldehyde derivative using the same reagents and conditions as in the reaction for synthesizing compound (6) from compound (5). The compound (2) can be synthesized by reacting 3-bromoperylene or perylene-3-ylboronic acid with an amine using a metal catalyst.
 化合物(9)は、例えば下記のスキームに従って、1-ニトロナフタレン-4-塩化スルホニルとナイルブルーとの反応により合成することができる。 Compound (9) can be synthesized, for example, by reacting 1-nitronaphthalene-4-sulfonyl chloride with Nile Blue according to the following scheme.
Figure JPOXMLDOC01-appb-C000043
Figure JPOXMLDOC01-appb-C000043
 本発明の第2の実施の形態に係る脂肪滴染色用組成物(以下、「脂肪滴染色用組成物」又は「組成物」と略称される場合がある。)は、上で説明した本発明の第1の実施の形態に係る蛍光色素、すなわち上記の一般式(I)、(II)又は(III)で表される蛍光色素の1又は複数を含んでいる。 The composition for fat droplet dyeing according to the second embodiment of the present invention (hereinafter, may be abbreviated as “composition for fat droplet dyeing” or “composition”) is the present invention described above. , Ie, one or more of the fluorescent dyes represented by the above general formulas (I), (II) or (III).
 組成物に用いることができる好ましい蛍光色素の具体例としては、下記の式(1)~(9)のいずれかで表されるものが挙げられる。化合物(7)及び化合物(8)は、公知化合物であるが、組成物に好ましく用いることができる。 具体 Specific examples of preferred fluorescent dyes that can be used in the composition include those represented by any of the following formulas (1) to (9). The compound (7) and the compound (8) are known compounds, but can be preferably used for the composition.
Figure JPOXMLDOC01-appb-C000044
Figure JPOXMLDOC01-appb-C000044
Figure JPOXMLDOC01-appb-C000045
Figure JPOXMLDOC01-appb-C000045
 組成物は、上記の蛍光色素の1又は複数を含む固体状のものであってもよいが、上記の蛍光色素の1又は複数を適当な溶媒、溶液又は緩衝溶液に溶解した液体状のものであってもよい。脂肪滴染色用組成物は、脂肪滴又は他のオルガネラの特異的又は非特異的染色に用いることができる1又は複数の他の色素を含んでいてもよい。 The composition may be in the form of a solid containing one or more of the above-mentioned fluorescent dyes, or in the form of a liquid in which one or more of the above-mentioned fluorescent dyes is dissolved in an appropriate solvent, solution or buffer solution. There may be. The composition for lipid droplet staining may comprise one or more other dyes that can be used for specific or non-specific staining of lipid droplets or other organelles.
 本発明の第3の実施の形態に係る細胞内脂肪滴のイメージング方法(以下、「イメージング方法」と略称される場合がある。)は、上記の一般式(I)、(II)又は(III)で表される1又は複数の蛍光色素を細胞内の脂肪滴の内部に導入する工程と、脂肪滴の内部に導入された蛍光色素から放出される蛍光を測定する工程とを含んでいる。 The method for imaging intracellular lipid droplets according to the third embodiment of the present invention (hereinafter, may be abbreviated as “imaging method”) may be any of the above general formulas (I), (II) and (III). ) And a step of measuring the fluorescence emitted from the fluorescent dye introduced into the lipid droplet inside the cell.
 イメージング方法に用いられる蛍光色素及びその好ましい具体例については、本発明の第2の実施の形態に係る脂肪滴染色用組成物の場合と同様であるので、詳しい説明は省略する。 蛍 光 Fluorescent dyes used in the imaging method and preferred specific examples thereof are the same as in the case of the composition for staining lipid droplets according to the second embodiment of the present invention, and thus detailed description is omitted.
 蛍光色素の脂肪滴の内部への導入は、任意の公知の方法を用いて行うことができるが、例えば、培地に播種した細胞に加え、所定時間インキュベートすることにより行うことができる。脂肪滴の内部に導入された蛍光色素から放出される蛍光の測定は、任意の公知の手段を用いて行うことができるが、共焦点顕微鏡や蛍光顕微鏡を用いた蛍光イメージの観察により行うことができる。イメージング方法に用いられる上述の蛍光色素は、細胞毒性が低く、脂肪滴内部への滞留性が高いため、生細胞内の脂肪滴の経時的な観察を行うこともできる。 The introduction of the fluorescent dye into the lipid droplets can be performed using any known method. For example, the fluorescent dye can be added to cells seeded in a medium and incubated for a predetermined time. The measurement of the fluorescence emitted from the fluorescent dye introduced inside the fat droplet can be performed using any known means, but can be performed by observing a fluorescent image using a confocal microscope or a fluorescent microscope. it can. Since the above-described fluorescent dye used in the imaging method has low cytotoxicity and high retention in fat droplets, it is possible to observe fat droplets in living cells over time.
 次に、本発明の作用効果を確認するために行った実施例について説明する。
実施例1:蛍光色素の合成
[1]:化合物(7)及び(3)の合成
 1-(4-メトキシフェニル)エテニル基を有する化合物(7)及び(3)の合成は、それぞれ、下記に示すスキームに従い、アルデヒド誘導体と、塩化(4-メトキシベンジル)トリフェニルホスホニウムとのWittig反応を用いて行った。
Next, an example performed to confirm the operation and effect of the present invention will be described.
Example 1 Synthesis of Fluorescent Dye [1]: Synthesis of Compounds (7) and (3) The synthesis of compounds (7) and (3) each having a 1- (4-methoxyphenyl) ethenyl group was as follows. According to the scheme shown, the reaction was carried out using a Wittig reaction between an aldehyde derivative and (4-methoxybenzyl) triphenylphosphonium chloride.
Figure JPOXMLDOC01-appb-C000046
Figure JPOXMLDOC01-appb-C000046
Figure JPOXMLDOC01-appb-C000047
Figure JPOXMLDOC01-appb-C000047
化合物(7)の合成
 100mLナスフラスコに、1-ピレンカルボキシアルデヒド(460mg、2.0mmol)、塩化(4-メトキシベンジル)トリフェニルホスホニウム(1,008mg、4.0mmol)、30mLのジクロロメタン、3mLの50%NaOH水溶液を加え、室温で終夜攪拌した。反応溶液をジクロロメタンで抽出し、抽出液をエバポレーターで留去した。精製はシリカゲルカラムを使用し、溶離液として100%クロロホルムを用いて行った。微黄色の結晶300mgを得た(収率44.9%)。
Synthesis of Compound (7) In a 100 mL eggplant flask, 1-pyrenecarboxaldehyde (460 mg, 2.0 mmol), (4-methoxybenzyl) triphenylphosphonium chloride (1,008 mg, 4.0 mmol), 30 mL of dichloromethane, and 3 mL of A 50% NaOH aqueous solution was added, and the mixture was stirred at room temperature overnight. The reaction solution was extracted with dichloromethane, and the extract was distilled off with an evaporator. Purification was performed using a silica gel column and 100% chloroform as an eluent. 300 mg of pale yellow crystals were obtained (44.9% yield).
 1H NMR (400 MHz, CDCl3): δ=3.81 (3H, s), 6.98 (2H, d, J=7.6 Hz), 7.31 (1H, 7.30, d, J=16.0 Hz), 7.63 (2H, d, J=7.6 Hz), 7.98-8.19 (8H, m), 8.31 (1H, d, J=8.0 Hz), 8.50 (1H, d, J=9.2 Hz). 1 H NMR (400 MHz, CDCl 3): δ = 3.81 (3H, s), 6.98 (2H, d, J = 7.6 Hz), 7.31 (1H, 7.30, d, J = 16.0 Hz), 7.63 (2H, d, J = 7.6 Hz), 7.98-8.19 (8H, m), 8.31 (1H, d, J = 8.0 Hz), 8.50 (1H, d, J = 9.2 Hz).
化合物(3)の合成
 100mLナスフラスコに、3-ペリレンカルボキシアルデヒド(8)(560mg、2.0mmol)、塩化(4-メトキシベンジル)トリフェニルホスホニウム(1,008mg、4.0mmol)、30mLのジクロロメタン、3mLの50%NaOH水溶液を加え、室温で終夜攪拌した。析出した結晶をろ過し、橙色の結晶198mgを得た(収率25.7%)。
Synthesis of Compound (3) In a 100 mL eggplant flask, 3-perylenecarboxaldehyde (8) (560 mg, 2.0 mmol), (4-methoxybenzyl) triphenylphosphonium chloride (1,008 mg, 4.0 mmol), 30 mL of dichloromethane Then, 3 mL of a 50% aqueous NaOH solution was added, and the mixture was stirred at room temperature overnight. The precipitated crystals were filtered to obtain 198 mg of orange crystals (yield 25.7%).
 1H NMR (400 MHz, CDCl3): δ=3.87 (3H, s), 6.95 (2H, d, J=7.2 Hz), 7.15 (1H, d, J=16.4 Hz), 7.47-7.57 (5H, m), 7.67-7.72 (3H, m), 7.75 (1H, J=7.6 Hz), 8.08 (1H, d, J=8.8 Hz), 8.19-8.25 (4H, m). 1 H NMR (400 MHz, CDCl 3): δ = 3.87 (3H, s), 6.95 (2H, d, J = 7.2 Hz), 7.15 (1H, d, J = 16.4 Hz), 7.47-7.57 (5H, m), 7.67-7.72 (3H, m), 7.75 (1H, J = 7.6 Hz), 8.08 (1H, d, J = 8.8 Hz), 8.19-8.25 (4H, m).
[2]:化合物(5)及び(6)の合成
 化合物(5)及び(6)の合成は、下記のスキームに従って行った。
[2]: Synthesis of Compounds (5) and (6) Compounds (5) and (6) were synthesized according to the following scheme.
Figure JPOXMLDOC01-appb-C000048
Figure JPOXMLDOC01-appb-C000048
3-ブロモペリレンの合成
 500mLナスフラスコに、ペリレン(1g、4.0mmol)、300mLのジクロロメタンを加え、1時間撹拌し溶解させた。この溶液に、N-ブロモスクシンイミド(1.78g、10.0mmol)を100mLのジクロロメタンに溶解させた溶液を滴下し、室温で終夜攪拌した。反応溶液をエバポレーターで濃縮し、黄色結晶を得た。結晶をメタノール100mLで洗浄し、黄色結晶1.6gを得た(収率:99%)。
Synthesis of 3-bromoperylene Perylene (1 g, 4.0 mmol) and 300 mL of dichloromethane were added to a 500 mL eggplant flask, and stirred for 1 hour to dissolve. To this solution, a solution of N-bromosuccinimide (1.78 g, 10.0 mmol) dissolved in 100 mL of dichloromethane was added dropwise, and the mixture was stirred at room temperature overnight. The reaction solution was concentrated by an evaporator to obtain yellow crystals. The crystals were washed with 100 mL of methanol to obtain 1.6 g of yellow crystals (yield: 99%).
 1H NMR (400 MHz, CDCl3): δ=7.48-7.52 (2H, m), 7.59 (1H, t, J=15.6 Hz), 7.67-7.73 (2H, m), 7.77 (1H, d, J=7.6 Hz), 8.01 (1H, d, J=8.4 Hz), 8.09 (1H, J=9.2 Hz), 8.17-8.26 (3H, m). 1 H NMR (400 MHz, CDCl 3 ): δ = 7.48-7.52 (2H, m), 7.59 (1H, t, J = 15.6 Hz), 7.67-7.73 (2H, m), 7.77 (1H, d, J = 7.6 Hz), 8.01 (1H, d, J = 8.4 Hz), 8.09 (1H, J = 9.2 Hz), 8.17-8.26 (3H, m).
化合物(5)の合成
 200mLナスフラスコに、3-ブロモペリレン(564mg、1.7mmol)、85mLのTHFを加え、-78℃のドライアイス-アセトン浴中で撹拌した。この溶液に、3mLのn-BuLi(4.8mmol)を滴下し、1時間攪拌した。その後、3-(N,N-ジメチルアミノ)アクロレイン(2g、20mmmol)を加え、終夜室温で攪拌した。反応溶液をエバポレーターで留去した。精製はシリカゲルカラムを使用し、溶離液として100%クロロホルムを用いて行った。微黄色の結晶220mg(収率:42.2%)を得た。
Synthesis of Compound (5) To a 200 mL eggplant flask were added 3-bromoperylene (564 mg, 1.7 mmol) and 85 mL of THF, and the mixture was stirred in a dry ice-acetone bath at -78 ° C. To this solution, 3 mL of n-BuLi (4.8 mmol) was added dropwise and stirred for 1 hour. Thereafter, 3- (N, N-dimethylamino) acrolein (2 g, 20 mmol) was added, and the mixture was stirred overnight at room temperature. The reaction solution was distilled off with an evaporator. Purification was performed using a silica gel column and 100% chloroform as an eluent. 220 mg (yield: 42.2%) of slightly yellow crystals were obtained.
 1H NMR (400 MHz, CDCl3): δ=6.87 (1H, dd, J=16.0, 8.8 Hz), 7.53 (2H, t, J=7.4 Hz), 7.62 (1H, t, J=4.0 Hz), 7.76 (2H, dd, J=8.8 Hz), 7.84 (1H, d, J=8.8 Hz), 8.05 (1H, d, J=8.4 Hz), 8.22-8.31 (5H, m), 9.86 (1H, d, J=8.4 Hz). 1 H NMR (400 MHz, CDCl 3): δ = 6.87 (1H, dd, J = 16.0, 8.8 Hz), 7.53 (2H, t, J = 7.4 Hz), 7.62 (1H, t, J = 4.0 Hz) , 7.76 (2H, dd, J = 8.8 Hz), 7.84 (1H, d, J = 8.8 Hz), 8.05 (1H, d, J = 8.4 Hz), 8.22-8.31 (5H, m), 9.86 (1H, d, J = 8.4 Hz).
化合物(6)の合成
 300mLナスフラスコに、化合物(5)(220mg、0.7mmol)、マロノニトリル(190mg、2.9mmol)、55mLのジクロロエタンを加え撹拌し溶解させた。この溶液に、2.9mLのTiCl(2.9mmol)、700μLのピリジンを加え、終夜還流した。室温に戻した後、反応溶液をジクロロメタンで抽出し、抽出液をエバポレーターで留去した。精製はシリカゲルカラムを使用し、溶離液として100%クロロホルムを用いて行った。黒紫色の結晶60mg(収率:23.5%)を得た。
Synthesis of Compound (6) Compound (5) (220 mg, 0.7 mmol), malononitrile (190 mg, 2.9 mmol), and 55 mL of dichloroethane were added to a 300-mL eggplant flask and stirred to dissolve. To this solution, 2.9 mL of TiCl 4 (2.9 mmol) and 700 μL of pyridine were added, and the mixture was refluxed overnight. After returning to room temperature, the reaction solution was extracted with dichloromethane, and the extract was distilled off with an evaporator. Purification was performed using a silica gel column and 100% chloroform as an eluent. 60 mg (yield: 23.5%) of black purple crystals were obtained.
 1H NMR (400 MHz, CDCl3): δ=7.41 (1H, t, J=13.0), 7.61 (3H, m), 7.76 (3H, m), 7.90 (1H, t, J=10.0 Hz), 7.98 (1H, d, J=8.0 Hz), 8.06 (1H, d, J =14.8 Hz), 8.23-8.32 (4H, m). 1 H NMR (400 MHz, CDCl 3 ): δ = 7.41 (1H, t, J = 13.0), 7.61 (3H, m), 7.76 (3H, m), 7.90 (1H, t, J = 10.0 Hz), 7.98 (1H, d, J = 8.0 Hz), 8.06 (1H, d, J = 14.8 Hz), 8.23-8.32 (4H, m).
化合物(9)の合成
 ナイルブルーと、1-ニトロナフタレン-4-塩化スルホニルとを、ジイソプロピルエチルアミンの存在下、DMF中で攪拌することにより、化合物(9)を合成した。
Synthesis of Compound (9) Compound (9) was synthesized by stirring Nile Blue and 1-nitronaphthalene-4-sulfonyl chloride in DMF in the presence of diisopropylethylamine.
実施例2:細胞内の脂肪滴の染色(1)
 化合物(7)、化合物(3)及び化合物(6)が、生細胞内の脂肪滴を特異的に染色できるか否かについて検討する目的で、脂肪滴が少ないがオレイン酸を添加することにより脂肪滴を誘導できるHeLa細胞及び脂肪滴含有量が高いHepG2細胞を用いて、脂肪滴の染色特性を検討した。
Example 2: Staining of lipid droplets in cells (1)
In order to examine whether the compound (7), the compound (3), and the compound (6) can specifically stain lipid droplets in living cells, the lipid droplets are small, but fat is added by adding oleic acid. The staining characteristics of lipid droplets were examined using HeLa cells capable of inducing droplets and HepG2 cells having a high lipid droplet content.
 HeLa細胞をμ-slide 8 well(Ibidi)に播種し、血清培地で希釈した200μmol/Lオレイン酸を添加し、37℃、COインキュベーターにて一晩培養した。血清培地で希釈した0.1μmol/Lの化合物(7)及び化合物(3)、1μmol/Lの化合物(6)を添加し、30分インキュベートした。その後、共焦点顕微鏡で観察した。 HeLa cells were seeded in μ-slide 8 well (Ibidi), 200 μmol / L oleic acid diluted with a serum medium was added, and the cells were cultured overnight at 37 ° C. in a CO 2 incubator. 0.1 μmol / L of the compound (7) and the compound (3) diluted with a serum medium were added, and 1 μmol / L of the compound (6) was added, and the mixture was incubated for 30 minutes. Thereafter, observation was performed with a confocal microscope.
 HepG2細胞をμ-slide 8 well(Ibidi)に播種し、37℃、COインキュベーターにて一晩培養した。血清培地で希釈した0.1μmol/Lの化合物(7)及び化合物(3)、1μmol/Lの化合物(6)を添加し、30分インキュベートした。その後、共焦点顕微鏡で観察した。 HepG2 cells were seeded in μ-slide 8 well (Ibidi) and cultured overnight at 37 ° C. in a CO 2 incubator. 0.1 μmol / L of the compound (7) and the compound (3) diluted with a serum medium were added, and 1 μmol / L of the compound (6) was added, and the mixture was incubated for 30 minutes. Thereafter, observation was performed with a confocal microscope.
 まず、200μmol/Lのオレイン酸処理によって脂肪滴を導入したHeLa細胞を用いて実験した。1μmol/Lの化合物(7)、化合物(3)及び化合物(6)をそれぞれ37℃で15分間インキュベートしたHeLa細胞について、共焦点顕微鏡を用いて評価した。結果を図1に示す。図1において、「DIC」は微分干渉像を、「FL」は蛍光像をそれぞれ示す(以下同様)。これらの結果から、細胞内に蛍光染色された部分が存在することが確認された。 First, an experiment was performed using HeLa cells into which lipid droplets were introduced by treatment with 200 μmol / L oleic acid. HeLa cells in which 1 μmol / L of compound (7), compound (3) and compound (6) were each incubated at 37 ° C. for 15 minutes were evaluated using a confocal microscope. The results are shown in FIG. In FIG. 1, "DIC" indicates a differential interference image, and "FL" indicates a fluorescent image (the same applies hereinafter). From these results, it was confirmed that a fluorescently stained portion was present in the cells.
 同時に、市販の脂肪滴インジケータであるNile Red(100nmol/L)との共染色実験から観察された蛍光より、化合物(3)は脂肪滴に局在していることを確認した(図2参照)。 At the same time, the fluorescence observed from a co-staining experiment with Nile Red (100 nmol / L), a commercially available lipid droplet indicator, confirmed that compound (3) was localized in the lipid droplets (see FIG. 2). .
 また、Nile Red及び同じく市販の脂肪滴インジケータであるBODYPY 493/503を用いてイメージング比較を行った(図3参照)。化合物(7)、化合物(3)及び化合物(6)のいずれについても、細胞の一部のみについて蛍光像が観測されたのに対し、Nile RedとBODYPY 493/503を用いた場合、細胞質全体から蛍光像が得られた。この結果より、化合物(7)、化合物(3)及び化合物(6)を用いた場合、脂肪滴に対して特異的に蛍光イメージが得られることが確認された。 イ メ ー ジ ン グ In addition, imaging comparison was performed using Nile Red and BODYPY 493/503, which is also a commercially available fat droplet indicator (see FIG. 3). In each of the compound (7), the compound (3) and the compound (6), a fluorescent image was observed only in a part of the cells, whereas when Nile Red and BODYPY $ 493/503 were used, the whole cytoplasm was A fluorescent image was obtained. From these results, it was confirmed that when the compound (7), the compound (3) and the compound (6) were used, a fluorescent image could be specifically obtained for fat droplets.
 さらに、脂肪滴の含有量が多いHepG2細胞を用いて、脂肪滴の染色24時間後の細胞の観察を行った。結果を図4に示す。Nile Red及びBODYPY 493/503はいずれも細胞内滞留性が低く、染色から24時間経過後には、色素が細胞から漏出し、脂肪滴に特異的な蛍光像が観察できないのに対し、化合物(7)及び化合物(3)を用いた場合には、染色から24時間経過後も、脂肪滴に特異的な蛍光像を維持したままであり、細胞内滞留性が高く、脂肪滴の長期間の観察を可能であることが確認された。 Furthermore, using HepG2 cells containing a large amount of lipid droplets, the cells were observed 24 hours after staining of the lipid droplets. FIG. 4 shows the results. Both Nile @ Red and BODYPY @ 493/503 have low intracellular retention properties, and after 24 hours from the staining, the dye leaks out of the cells and a fluorescent image specific to lipid droplets cannot be observed. ) And compound (3), the fluorescence image specific to the lipid droplets is maintained even after 24 hours from the staining, the retention in the cell is high, and the lipid droplets are observed for a long period of time. It was confirmed that it was possible.
実施例3:細胞内の脂肪滴の染色(2)
 フローサイトメーターは、簡便、迅速かつ高感度に個々の細胞単位での蛍光強度を検出し、細胞集団の特性を数値化することが可能である。フローサイトメーターを用いて脂肪滴を解析する場合、検出される蛍光シグナルは細胞に標識されている蛍光色素の量に依存するため、より高い脂肪滴特異性が必要となる。また、フローサイトメーター解析において、細胞が短波長領域で自家蛍光の問題を引き起こすことがある。細胞の構成物質により488nmレーザーで励起され、蛍光染色されていなくても僅かな発光を起こし、偽陽性が検出される場合がある。より長波長側では自家蛍光の干渉が少なくなるので、600nmを超える蛍光を発する蛍光色素が求められる。化合物(9)を用いて、細胞内脂肪滴量のフローサイトメーターによる評価を検討した。
Example 3: Staining of lipid droplets in cells (2)
The flow cytometer can detect the fluorescence intensity of each individual cell simply, quickly and with high sensitivity, and can quantify the characteristics of the cell population. When analyzing lipid droplets using a flow cytometer, a higher lipid droplet specificity is required because the detected fluorescent signal depends on the amount of fluorescent dye labeled on the cells. In flow cytometer analysis, cells sometimes cause autofluorescence in a short wavelength region. Excitation by a 488 nm laser caused by a constituent material of the cell causes slight emission even without fluorescent staining, and false positives may be detected. On the longer wavelength side, auto-fluorescence interference is reduced, and a fluorescent dye that emits fluorescence exceeding 600 nm is required. Using the compound (9), evaluation of the amount of intracellular lipid droplets by a flow cytometer was examined.
 200μmol/Lオレイン酸処理(図5、6中に「OA」で示した。)によって脂肪滴を導入したHeLa細胞と5μmol/L Triacsin C(アシル-CoA合成酵素阻害剤)を添加し(図5、6中に「TC」で示した。)脂肪滴を減少させたHeLa細胞を調整し、0.5μmol/Lの化合物(9)を、それぞれ37℃で2時間インキュベートしたHeLa細胞について、フローサイトメーターを用いて評価した。結果を図5に示す。図5の結果より、細胞内の脂肪滴量の変化が、フローサイトメーターにより蛍光強度の変化として読み出し可能であることが確認された。 HeLa cells into which lipid droplets were introduced by treatment with 200 μmol / L oleic acid (indicated by “OA” in FIGS. 5 and 6) and 5 μmol / L TriacsinΔC (acyl-CoA synthetase inhibitor) were added (FIG. 5). , 6).) HeLa cells with reduced lipid droplets were prepared, and 0.5 μmol / L of compound (9) was incubated at 37 ° C. for 2 hours. Evaluation was performed using a meter. FIG. 5 shows the results. From the results of FIG. 5, it was confirmed that the change in the amount of intracellular lipid droplets can be read out as a change in the fluorescence intensity by the flow cytometer.
 図6において、オレイン酸処理したHeLa細胞(OL)と未処理のHeLa細胞(Control)において得られたヒストグラムを比較すると、有意な蛍光強度の差が観察された。この結果より、化合物(9)が、脂肪滴を特異的に染色し、フローサイトメーターを用いた細胞内の脂肪適量の評価において、実用的な試薬であることが明らかとなった。 に お い て Comparing the histograms obtained in FIG. 6 between HeLa cells treated with oleic acid (OL) and untreated HeLa cells (Control), a significant difference in fluorescence intensity was observed. From the results, it was revealed that the compound (9) specifically stains lipid droplets and is a practical reagent in evaluating an appropriate amount of intracellular fat using a flow cytometer.
 また、未処理のHeLa細胞(Control)と脂肪滴形成を阻害したHeLa細胞(TC)において得られたヒストグラムを比較すると、細胞内の蛍光シグナルが減弱するのを確認できた。この結果は、化合物(9)が脂肪滴阻害剤の探索についても有用であることを示している。 Comparing the histograms obtained with untreated HeLa cells (Control) and those obtained with HeLa cells (TC) that inhibited lipid droplet formation, it was confirmed that the intracellular fluorescence signal was attenuated. This result indicates that compound (9) is also useful for searching for a lipid droplet inhibitor.
 なお、本発明は、本発明の広義の精神と範囲を逸脱することなく、様々な実施形態及び変形が可能とされるものである。また、上述した実施形態は、本発明を説明するためのものであり、本発明の範囲を限定するものではない。つまり、本発明の範囲は、実施形態ではなく、請求の範囲によって示される。そして、請求の範囲内及びそれと同等の発明の意義の範囲内で施される様々な変形が、本発明の範囲内とみなされる。 The present invention allows various embodiments and modifications without departing from the broad spirit and scope of the present invention. Further, the above-described embodiment is for describing the present invention, and does not limit the scope of the present invention. That is, the scope of the present invention is shown not by the embodiment but by the claims. Various modifications made within the scope of the claims and equivalents thereof are considered to be within the scope of the present invention.
 本出願は、2018年8月28日に出願された日本国特許出願2018-158925号に基づくものであり、その明細書、特許請求の範囲、図面および要約書を含むものである。上記日本国特許出願における開示は、その全体が本明細書中に参照として含まれる。 This application is based on Japanese Patent Application No. 2018-158925 filed on August 28, 2018 and includes the specification, claims, drawings, and abstract. The disclosure in the above-mentioned Japanese Patent Application is incorporated herein by reference in its entirety.

Claims (6)

  1.  下記の一般式(I)、(II)又は(III)で表される蛍光色素。
    Figure JPOXMLDOC01-appb-C000001
    Figure JPOXMLDOC01-appb-C000002
    Figure JPOXMLDOC01-appb-C000003
     上記一般式(I)、(II)及び(III)において、R及びRは、それぞれ独立して、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、且つR及びRのうち少なくとも一方は、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基のいずれかであり、
     Rは、下記の一般式(i)、(ii)及び(iii)のいずれかで表される官能基、R11は、下記の一般式(i)で表される官能基であり、R12は、ニトロ基、シアノ基、スルホニル基、スルホキシル基、カルボニル基及びカルボキシル基のいずれかであり、
    Figure JPOXMLDOC01-appb-C000004
     上記一般式(i)、(ii)及び(iii)において、
     R及びRは、それぞれ独立して、炭素数1~10の、分岐及び不飽和結合の一方又は双方を含んでいてもよい炭化水素基であり、R及びRは、直接或いは炭素原子、酸素原子、窒素原子及び硫黄原子のいずれかを介して結合し、環を形成していてもよく、
     R及びRは、それぞれ独立して、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、且つR及びRのうち少なくとも一方は、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基のいずれかであり、
     Rは、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、
     R及びR10は、それぞれ独立して、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、且つR及びR10のうち少なくとも一方は、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基のいずれかである。
    A fluorescent dye represented by the following general formula (I), (II) or (III).
    Figure JPOXMLDOC01-appb-C000001
    Figure JPOXMLDOC01-appb-C000002
    Figure JPOXMLDOC01-appb-C000003
    In the above general formulas (I), (II) and (III), R 1 and R 2 each independently represent a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted hetero group. Selected from the group consisting of aryl groups, and at least one of R 1 and R 2 is any one of a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group, and a substituted heteroaryl group;
    R 3 is a functional group represented by any of the following general formulas (i), (ii), and (iii); R 11 is a functional group represented by the following general formula (i); 12 is a nitro group, a cyano group, a sulfonyl group, a sulfoxyl group, a carbonyl group or a carboxyl group,
    Figure JPOXMLDOC01-appb-C000004
    In the above general formulas (i), (ii) and (iii),
    R 4 and R 5 are each independently a hydrocarbon group having 1 to 10 carbon atoms and optionally containing one or both of a branched and unsaturated bond, and R 4 and R 5 are directly or An atom, an oxygen atom, a nitrogen atom and a sulfur atom may be bonded to each other to form a ring,
    R 6 and R 7 are each independently selected from the group consisting of a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group, and R 6 and R 7 At least one of them is a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group or a substituted heteroaryl group,
    R 8 is selected from the group consisting of a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group;
    R 9 and R 10 are each independently selected from the group consisting of a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group, and R 9 and R 10 At least one of them is any of a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group, and a substituted heteroaryl group.
  2.  下記の式(1)~(6)及び(9)のいずれかで表されることを特徴とする請求項1に記載の蛍光色素。
    Figure JPOXMLDOC01-appb-C000005
    Figure JPOXMLDOC01-appb-C000006
    The fluorescent dye according to claim 1, wherein the fluorescent dye is represented by any one of the following formulas (1) to (6) and (9).
    Figure JPOXMLDOC01-appb-C000005
    Figure JPOXMLDOC01-appb-C000006
  3.  下記の一般式(I)、(II)又は(III)で表される1又は複数の蛍光色素を含む脂肪滴染色用組成物。
    Figure JPOXMLDOC01-appb-C000007
    Figure JPOXMLDOC01-appb-C000008
    Figure JPOXMLDOC01-appb-C000009
     上記一般式(I)、(II)及び(III)において、R及びRは、それぞれ独立して、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、且つR及びRのうち少なくとも一方は、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基のいずれかであり、
     Rは、ホルミル基又は下記の一般式(i)、(ii)及び(iii)のいずれかで表される官能基、R11は、下記の一般式(i)で表される官能基であり、R12は、ニトロ基、シアノ基、スルホニル基、スルホキシル基、カルボニル基及びカルボキシル基のいずれかであり、
    Figure JPOXMLDOC01-appb-C000010
     上記一般式(i)、(ii)及び(iii)において、
     R及びRは、それぞれ独立して、炭素数1~10の、分岐及び不飽和結合の一方又は双方を含んでいてもよい炭化水素基であり、R及びRは、直接或いは炭素原子、酸素原子、窒素原子及び硫黄原子のいずれかを介して結合し、環を形成していてもよく、
     R及びRは、それぞれ独立して、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、且つR及びRのうち少なくとも一方は、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基のいずれかであり、
     Rは、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、
     R及びR10は、それぞれ独立して、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、且つR及びR10のうち少なくとも一方は、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基のいずれかである。
    A composition for staining lipid droplets, comprising one or more fluorescent dyes represented by the following general formulas (I), (II) or (III).
    Figure JPOXMLDOC01-appb-C000007
    Figure JPOXMLDOC01-appb-C000008
    Figure JPOXMLDOC01-appb-C000009
    In the above general formulas (I), (II) and (III), R 1 and R 2 each independently represent a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted hetero group. Selected from the group consisting of aryl groups, and at least one of R 1 and R 2 is any one of a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group, and a substituted heteroaryl group;
    R 3 is a formyl group or a functional group represented by any of the following general formulas (i), (ii) and (iii), and R 11 is a functional group represented by the following general formula (i) R 12 is any one of a nitro group, a cyano group, a sulfonyl group, a sulfoxyl group, a carbonyl group and a carboxyl group;
    Figure JPOXMLDOC01-appb-C000010
    In the above general formulas (i), (ii) and (iii),
    R 4 and R 5 are each independently a hydrocarbon group having 1 to 10 carbon atoms and optionally containing one or both of a branched and unsaturated bond, and R 4 and R 5 are directly or An atom, an oxygen atom, a nitrogen atom and a sulfur atom may be bonded to each other to form a ring,
    R 6 and R 7 are each independently selected from the group consisting of a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group, and R 6 and R 7 At least one of them is a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group or a substituted heteroaryl group,
    R 8 is selected from the group consisting of a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group;
    R 9 and R 10 are each independently selected from the group consisting of a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group, and R 9 and R 10 At least one of them is any of a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group, and a substituted heteroaryl group.
  4.  前記蛍光色素が、下記の式(1)~(9)のいずれかで表されることを特徴とする請求項3に記載の脂肪滴染色用組成物。
    Figure JPOXMLDOC01-appb-C000011
    Figure JPOXMLDOC01-appb-C000012
    4. The composition for staining lipid droplets according to claim 3, wherein the fluorescent dye is represented by any of the following formulas (1) to (9).
    Figure JPOXMLDOC01-appb-C000011
    Figure JPOXMLDOC01-appb-C000012
  5.  下記の一般式(I)、(II)又は(III)で表される1又は複数の蛍光色素を細胞内の脂肪滴の内部に導入する工程と、
     脂肪滴の内部に導入された前記蛍光色素から放出される蛍光を測定する工程とを含むことを特徴とする細胞内脂肪滴のイメージング方法。
    Figure JPOXMLDOC01-appb-C000013
    Figure JPOXMLDOC01-appb-C000014
    Figure JPOXMLDOC01-appb-C000015
     上記一般式(I)(II)及び(III)において、R及びRは、それぞれ独立して、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、且つR及びRのうち少なくとも一方は、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基のいずれかであり、
     Rは、ホルミル基又は下記の一般式(i)、(ii)及び(iii)のいずれかで表される官能基、R11は、下記の一般式(i)で表される官能基であり、R12は、ニトロ基、シアノ基、スルホニル基、スルホキシル基、カルボニル基及びカルボキシル基のいずれかであり、
    Figure JPOXMLDOC01-appb-C000016
     上記一般式(i)、(ii)及び(iii)において、
     R及びRは、それぞれ独立して、炭素数1~10の、分岐及び不飽和結合の一方又は双方を含んでいてもよい炭化水素基であり、R及びRは、直接或いは炭素原子、酸素原子、窒素原子及び硫黄原子のいずれかを介して結合し、環を形成していてもよく、
     R及びRは、それぞれ独立して、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、且つR及びRのうち少なくとも一方は、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基のいずれかであり、
     Rは、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、
     R及びR10は、それぞれ独立して、水素原子、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基からなる群より選択され、且つR及びR10のうち少なくとも一方は、シアノ基、ホルミル基、アリール基、置換アリール基、ヘテロアリール基及び置換ヘテロアリール基のいずれかである。
    A step of introducing one or a plurality of fluorescent dyes represented by the following general formulas (I), (II) or (III) into lipid droplets in cells;
    Measuring the fluorescence emitted from the fluorescent dye introduced into the inside of the lipid droplet.
    Figure JPOXMLDOC01-appb-C000013
    Figure JPOXMLDOC01-appb-C000014
    Figure JPOXMLDOC01-appb-C000015
    In the general formulas (I), (II) and (III), R 1 and R 2 each independently represent a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group, and a substituted heteroaryl Selected from the group consisting of groups, and at least one of R 1 and R 2 is any one of a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group, and a substituted heteroaryl group;
    R 3 is a formyl group or a functional group represented by any of the following general formulas (i), (ii) and (iii), and R 11 is a functional group represented by the following general formula (i) R 12 is any one of a nitro group, a cyano group, a sulfonyl group, a sulfoxyl group, a carbonyl group and a carboxyl group;
    Figure JPOXMLDOC01-appb-C000016
    In the above general formulas (i), (ii) and (iii),
    R 4 and R 5 are each independently a hydrocarbon group having 1 to 10 carbon atoms and optionally containing one or both of a branched and unsaturated bond, and R 4 and R 5 are directly or An atom, an oxygen atom, a nitrogen atom and a sulfur atom may be bonded to each other to form a ring,
    R 6 and R 7 are each independently selected from the group consisting of a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group, and R 6 and R 7 At least one of them is a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group or a substituted heteroaryl group,
    R 8 is selected from the group consisting of a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group;
    R 9 and R 10 are each independently selected from the group consisting of a hydrogen atom, a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group and a substituted heteroaryl group, and R 9 and R 10 At least one of them is any of a cyano group, a formyl group, an aryl group, a substituted aryl group, a heteroaryl group, and a substituted heteroaryl group.
  6.  前記蛍光色素が、下記の式(1)~(9)のいずれかで表されることを特徴とする請求項5に記載の細胞内脂肪滴のイメージング方法。
    Figure JPOXMLDOC01-appb-C000017
    Figure JPOXMLDOC01-appb-C000018
    The imaging method for intracellular lipid droplets according to claim 5, wherein the fluorescent dye is represented by any of the following formulas (1) to (9).
    Figure JPOXMLDOC01-appb-C000017
    Figure JPOXMLDOC01-appb-C000018
PCT/JP2019/033790 2018-08-28 2019-08-28 Novel fluorescent dye, composition for lipid droplet staining using same, and method for imaging intracellular lipid droplets using same WO2020045529A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018158925A JP2021191807A (en) 2018-08-28 2018-08-28 Novel fluorescent dye, and composition for lipid droplet staining and method for imaging intracellular lipid droplets using the same
JP2018-158925 2018-08-28

Publications (1)

Publication Number Publication Date
WO2020045529A1 true WO2020045529A1 (en) 2020-03-05

Family

ID=69643576

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2019/033790 WO2020045529A1 (en) 2018-08-28 2019-08-28 Novel fluorescent dye, composition for lipid droplet staining using same, and method for imaging intracellular lipid droplets using same

Country Status (2)

Country Link
JP (1) JP2021191807A (en)
WO (1) WO2020045529A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6241014B2 (en) * 2013-03-15 2017-12-06 国立研究開発法人理化学研究所 Novel compound and lipid droplet and / or adipose tissue detection reagent containing the compound

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6241014B2 (en) * 2013-03-15 2017-12-06 国立研究開発法人理化学研究所 Novel compound and lipid droplet and / or adipose tissue detection reagent containing the compound

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
CASTEL, NELLY ET AL.: "Photophysics and reversible photochemistry of 1, 2-diarylethylenes containing perylenyl or biphenylenyl as an aryl group", JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY, A: CHEMISTRY, vol. 57, no. 1-3, 1991, pages 301 - 15, XP055697425, ISSN: 1010-6030 *
KATRITZKY, ALAN R. ET AL.: "Intramolecular charge transfer properties of dicyanovinyl-substituted aromatics", JOURNAL OF PHYSICAL CHEMISTRY, vol. 95, no. 15, 1991, pages 5737 - 5742, XP055697431, ISSN: 0022-3654 *
KIM, EUNHA ET AL.: "A Seoul-Fluor-based bioprobe for lipid droplets and its application in image-based high throughput screening", CHEMICAL COMMUNICATIONS, vol. 48, no. 17, 2012, pages 2331 - 2333, XP055697435, ISSN: 1359-7345 *
MAEDA, YOSHIHIRO ET AL.: "Photoinduced trans ? cis isomerization and intramolecular-charge-transfer interaction", PHOTOCHEMISTRY AND PICOSECOND LASER SPECTROSCOPY OF 4-SUBSTITUTED BETA-(1-PYRENYL)STYRENES, JOURNAL OF PHYSICAL CHEMISTRY, vol. 88, no. 13, 1984, pages 2714 - 2718, XP055697429, ISSN: 0022-3654 *
NIU, GUANGLE ET AL.: "Specific Two-Photon Imaging of Live Cellular and Deep-Tissue Lipid Droplets by Lipophilic AIEgens at Ultralow Concentration", CHEMISTRY OF MATERIALS, vol. 30, no. 14, 2 July 2018 (2018-07-02), pages 4778 - 4787, XP055697432, ISSN: 0897-4756 *
OKA, MASAKO ET AL.: "Exogenous Cytokine-Free Differentiation of Human Pluripotent Stem Cells into Classical Brown Adipocytes", CELLS, vol. 8, no. 4, 24 April 2019 (2019-04-24), pages 373, XP055697438, ISSN: 2073-4409, Retrieved from the Internet <URL:https://www.mdpi.com/2073-4409/8/4/373> [retrieved on 20191021] *
SONG, CHANG WOOK ET AL.: "A rationally designed polarity-viscosity sensitive probe for imaging lipid droplets", DYES AND PIGMENTS, vol. 171, no. 107718, 17 July 2019 (2019-07-17), pages 1 - 8, XP085790410, ISSN: 0143-7208, Retrieved from the Internet <URL:https://www.sciencedirect.com/science/article/pii/S0143720819314627> [retrieved on 20191021], DOI: 10.1016/j.dyepig.2019.107718 *
TATENAKA, YUKI ET AL.: "Monitoring Lipid Droplet Dynamics in Living Cells by Using Fluorescent", BIOCHEMISTRY, vol. 58, no. 6, 2019, pages 499 - 503, XP055697436, ISSN: 0006-2960 *
USTINOV, A. V. ET AL.: "Oligonucleotides containing arylacetylene residues: Synthesis and post-synthetic modification via [3+2] cycloaddition", RUSSIAN CHEMICAL BULLETIN, INTERNATIONAL EDITION, vol. 55, no. 7, 2006, pages 1268 - 1274, XP019454004, ISSN: 1066-5285, DOI: 10.1007/s11172-006-0410-0 *

Also Published As

Publication number Publication date
JP2021191807A (en) 2021-12-16

Similar Documents

Publication Publication Date Title
Liu et al. An AIE+ ESIPT ratiometric fluorescent probe for monitoring sulfur dioxide with distinct ratiometric fluorescence signals in mammalian cells, mouse embryonic fibroblast and zebrafish
Robinson et al. The selective detection of mitochondrial superoxide by live cell imaging
US9315465B2 (en) Photostable AIE luminogens for specific mitochondrial imaging and its method of manufacturing thereof
Li et al. A near-infrared fluorescent probe for imaging of endogenous hydrogen sulfide in living cells and mice
Wang et al. A cyanine-based colorimetric and fluorescence probe for detection of hydrogen sulfide in vivo
CN110981842B (en) Fluorescent probe for distinguishing normal cells and cancer cells and specifically detecting lipid droplets and application
Tan et al. A novel “off–on” colorimetric and fluorescent rhodamine-based pH chemosensor for extreme acidity
WO2015174460A1 (en) Enzyme-specific fluorescent compound capable of being retained in cells
Liu et al. A squaraine-based red emission off–on chemosensor for biothiols and its application in living cells imaging
JP6849983B2 (en) Enzyme-specific intracellular retention red fluorescent probe.
CN107200718A (en) Detect compound, method and the kit of the serobilas of DNA G tetra-
Resa et al. New dual fluorescent probe for simultaneous biothiol and phosphate bioimaging
Yuan et al. A mitochondrion-targeting turn-on fluorescent probe detection of endogenous hydroxyl radicals in living cells and zebrafish
Zhang et al. A two-photon endoplasmic reticulum-targeting fluorescent probe for the imaging of pH in living cells and zebrafish
Chen et al. A bright two-photon fluorescence probe with large stokes shift for deep tissue imaging of H2S during metabolism
CN106631980B (en) A kind of water-soluble biological thiol two-photon fluorescence probe and its preparation method and application
Zhu et al. Real-time detection of attenuated blood polarity in mouse models of circulating tumor based on a fluorescent probe
Pei et al. Synthesis of a new environment-sensitive fluorescent probe based on TICT and application for detection of human serum albumin and specific lipid droplets imaging
CN102093270A (en) Stilbene two-photon fluorescence probe for detecting intracellular silver ions
Tian et al. A lipid droplets-targetable fluorescent probe for polarity detection in cells of iron death, inflammation and fatty liver tissue
WO2008155593A2 (en) Phthalimide derivatives for labeling lipid droplets, and a method for visualization of cells and/or cellular organelles
WO2020045529A1 (en) Novel fluorescent dye, composition for lipid droplet staining using same, and method for imaging intracellular lipid droplets using same
JPWO2018174253A1 (en) Nitrobenzene derivatives or their salts and their uses
Kim et al. A Bright Surprise: Live‐Cell Labeling with Negatively Charged Fluorescent Probes based on Disulfonated Rhodamines and HaloTag
Wang et al. Regulation of the alkyl chain of fluorescent probes to selectively target the cell membrane or mitochondria in living cells

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19856287

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19856287

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP